The effect on hormone excretion patterns of depot medroxyprogesterone acetate used as a contraceptive preparation.
Bloch
B
B
D001695:Biology; D002490:Central Nervous System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D004703:Endocrine System; D004964:Estriol; D004967:Estrogens; D005193:Family Planning Services; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006728:Hormones; D007031:Hypothalamus; D007267:Injections; D007986:Luteinizing Hormone; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D010060:Ovulation; D010827:Physiology; D010902:Pituitary Gland; D012106:Research; D014621:Vagina; D014627:Vaginitis
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004967:Estrogens; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006728:Hormones; D007986:Luteinizing Hormone; D017258:Medroxyprogesterone Acetate; D004964:Estriol
Biology; Central Nervous System; Clinical Research; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Depo-provera; Diseases; Endocrine System; Estriol--analysis; Estrogens--analysis; Family Planning; Gonadotropins; Gonadotropins, Pituitary; Hormones; Hypothalamus; Injectables; Luteinizing Hormone--analysis; Medroxyprogesterone Acetate--side effects; Menstruation Disorders--etiology; Ovulation Suppression; Physiology; Pituitary Gland; Research Methodology; Vaginal Abnormalities; Vaginal Desquamate Effects; Vaginitis